Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Part D Is “Stable” Feature Of Health Landscape; 2008 Enrollment Up 6%

Executive Summary

"Begun just two years ago, Medicare's Part D prescription drug program is now well on its way to becoming a stable and familiar part of the nation's health care landscape," CMS Acting Administrator Kerry Weems concluded Jan. 31

You may also be interested in...



Medicare Part D Boosts Public Share Of Retail Drug Spending To 34 Percent

The public sector picked up 34 percent of the tab for prescription drugs purchased at retail in 2006, up from 28 percent the year before, with Medicare Part D underlying much of that shift, according to a report by CMS economists

Part D Enrollment, Formularies And Other Medicare Drug Coverage In Brief

Part D Membership Stability

Benzodiazepine Coverage Among Medicare Provisions In Child Health Bill

Makers of benzodiazepines could see wider use of their products by Medicare Part D enrollees, under a provision of the child health/Medicare legislative package that cleared the House Ways and Means Committee July 27

Related Content

UsernamePublicRestriction

Register

PS049269

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel